PIPELINE
EP282 - FFAR2
EPICS’ EP282 – FFAR2: Ready to enter Phase II clinical development, targeting the microbiome–immune axis to treat autoimmune disease.
This section is currently being updated. Please visit again soon.
PIPELINE
EPICS’ EP282 – FFAR2: Ready to enter Phase II clinical development, targeting the microbiome–immune axis to treat autoimmune disease.
This section is currently being updated. Please visit again soon.